Thursday, December 4, 2014

Crisis In Pharmaceutical R&D: It Costs $2.6 Billion To Research And Develop A New Drug

The rate of growth of health spending remains moderate. But one area where prices appear to be increasing faster than they have in the past few years is brand-name prescription drugs. By 2012, blockbusters had lost their patents, and many looked forward to a future where we could all get a month-long supply of generic drugs for $4. Well, it did not quite work out that way.

Read the entire article at Forbes.

No comments: